These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 1726078)
21. Angiopoietin-like protein 3 and 4 expression 4 and their serum levels in hepatocellular carcinoma. El-Shal AS; Zidan HE; Rashad NM; Wadea FM Cytokine; 2017 Aug; 96():75-86. PubMed ID: 28371666 [TBL] [Abstract][Full Text] [Related]
22. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis. Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863 [TBL] [Abstract][Full Text] [Related]
23. Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma. Sun Y; Zhu S; Wu Z; Huang Y; Liu C; Tang S; Wei L Oncotarget; 2017 Apr; 8(14):23427-23435. PubMed ID: 28178643 [TBL] [Abstract][Full Text] [Related]
24. Serological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseases. Tian L; Wang Y; Xu D; Gui J; Jia X; Tong H; Wen X; Dong Z; Tian Y Int J Cancer; 2011 Oct; 129(8):1923-31. PubMed ID: 21140449 [TBL] [Abstract][Full Text] [Related]
25. Determination of UDP-N-acetylglucosamine: beta-D-mannoside-1,4-N-acetylglucosaminyltransferase-III in patients sera with chronic hepatitis and liver cirrhosis using a monoclonal antibody. Song EY; Kim KS; Kim KA; Kim YD; Kwon DH; Byun SM; Kim HJ; Chung TW; Choe YK; Chung TW; Kim CH Glycoconj J; 2002 Jul; 19(6):415-21. PubMed ID: 14707488 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of annexin II as a potential serum marker for hepatocellular carcinoma using a developed sandwich ELISA method. Ji NY; Park MY; Kang YH; Lee CI; Kim DG; Yeom YI; Jang YJ; Myung PK; Kim JW; Lee HG; Kim JW; Lee K; Song EY Int J Mol Med; 2009 Dec; 24(6):765-71. PubMed ID: 19885616 [TBL] [Abstract][Full Text] [Related]
27. Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma. Gad A; Tanaka E; Matsumoto A; Wahab MA; Serwah Ael-H; Attia F; Ali K; Hassouba H; el-Deeb Ael-R; Ichijyo T; Umemura T; Muto H; Yoshizawa K; Kiyosawa K World J Gastroenterol; 2005 Nov; 11(42):6607-12. PubMed ID: 16425352 [TBL] [Abstract][Full Text] [Related]
28. Assessment of the Clinical Utility of Glypican 3 as a Serum Marker for the Diagnosis of Hepatocellular Carcinoma. Jia X; Gao Y; Zhai D; Liu J; Cai J; Wang Y; Jing L; Du Z Technol Cancer Res Treat; 2016 Dec; 15(6):780-786. PubMed ID: 26370140 [TBL] [Abstract][Full Text] [Related]
29. Blocking monoclonal antibodies to alpha V beta 3 integrin: a unique epitope of alpha V beta 3 integrin is present on human osteoclasts. Chuntharapai A; Bodary S; Horton M; Kim KJ Exp Cell Res; 1993 Apr; 205(2):345-52. PubMed ID: 7683273 [TBL] [Abstract][Full Text] [Related]
30. A monoclonal antibody inhibits adhesion to fibronectin and vitronectin of a colon carcinoma cell line and recognizes the integrins alpha v beta 3, alpha v beta 5, and alpha v beta 6. Lehmann M; Rabenandrasana C; Tamura R; Lissitzky JC; Quaranta V; Pichon J; Marvaldi J Cancer Res; 1994 Apr; 54(8):2102-7. PubMed ID: 7513610 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis. Wang Y; Liu YH; Mai SJ; He LJ; Liao YJ; Deng HX; Guan XY; Zeng YX; Kung HF; Xie D J Gastroenterol Hepatol; 2010 Jun; 25(6):1123-8. PubMed ID: 20594228 [TBL] [Abstract][Full Text] [Related]
32. A vitronectin-receptor-related molecule in human placental brush border membranes. Vanderpuye OA; Labarrere CA; McIntyre JA Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):9-17. PubMed ID: 1720617 [TBL] [Abstract][Full Text] [Related]
33. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma. Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138 [TBL] [Abstract][Full Text] [Related]
34. Serum transforming growth factor alpha level as a marker of hepatocellular carcinoma complicating cirrhosis. Tomiya T; Fujiwara K Cancer; 1996 Mar; 77(6):1056-60. PubMed ID: 8635123 [TBL] [Abstract][Full Text] [Related]
35. Identification and characterization of monoclonal antibodies against GP73 for use as a potential biomarker in liver cancer screening and diagnosis. Zhang Y; Xi Y; Fang J; Luo S; Wilson JJ; Huang RP J Immunoassay Immunochem; 2016; 37(4):390-406. PubMed ID: 27088654 [TBL] [Abstract][Full Text] [Related]
36. Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases. Van Tong H; Van Ba N; Hoan NX; Binh MT; Quyen DT; Son HA; Van Luong H; Quyet D; Meyer CG; Song LH; Toan NL; Velavan TP BMC Infect Dis; 2018 Nov; 18(1):553. PubMed ID: 30419833 [TBL] [Abstract][Full Text] [Related]
37. Serum talin-1 is a potential novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients. Youns MM; Abdel Wahab AH; Hassan ZA; Attia MS Asian Pac J Cancer Prev; 2013; 14(6):3819-23. PubMed ID: 23886189 [TBL] [Abstract][Full Text] [Related]
38. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma. Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938 [TBL] [Abstract][Full Text] [Related]
39. A novel monoclonal antibody, L1A3, is directed to the functional site of the alpha v integrin subunit. Deryugina EI; Strongin A; Yu C; Bourdon MA Hybridoma; 1996 Aug; 15(4):279-88. PubMed ID: 8880215 [TBL] [Abstract][Full Text] [Related]
40. A useful ELISA system for human liver-type arginase, and its utility in diagnosis of liver diseases. Ikemoto M; Tsunekawa S; Awane M; Fukuda Y; Murayama H; Igarashi M; Nagata A; Kasai Y; Totani M Clin Biochem; 2001 Sep; 34(6):455-61. PubMed ID: 11676974 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]